Dublin, April 20, 2026 (GLOBE NEWSWIRE)-- The "Viral Vector and Plasmid DNA Manufacturing Market (7th Edition): Industry Trends and Global Forecasts, till 2035" report has been added to ...

The plasmid DNA manufacturing market is witnessing strong growth driven by rising demand for gene therapies, DNA vaccines, and cell-based therapies such as CAR-T treatments. Increasing clinical trials ...

PlasmidFactory GmbH and the Fraunhofer Institute for Cell Therapy and Immunology IZI have signed a Memorandum of Understanding to combine expertise in cell therapy process development and GMP ...

New York, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report 'Viral Vectors And Plasmid DNA Global Market Report 2023' - The global viral vectors & plasmid DNA ...

Viral vectors dominate gene therapy, with lentivirus, adenovirus, and AAV being key players, each with unique advantages and limitations. Non-viral vectors, such as lipid nanoparticles and GalNAc, ...

Polymer-based gene delivery systems represent a promising class of non-viral vectors, offering significant advantages in safety, structural versatility, biodegradability, and the potential for ...

(MENAFN- GlobeNewsWire - Nasdaq) The globe viral vectors & plasmid DNA manufacturing market size is expected to be lead USD 29.82 billion by 2035, increasing from USD 7.26 billion in 2025, with a ...

In 2025, North America led the viral vectors and plasmid DNA manufacturing market, contributing 49% of the total revenue. Among vector types, the AAV segment emerged as a key growth driver, accounting ...